- Home
- RLGT vs CCCC Comparison
RLGT vs CCCC Comparison
Compare RLGT & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLGT
- CCCC
- Stock Information
- Founded
- RLGT 2001
- CCCC 2015
- Country
- RLGT United States
- CCCC United States
- Employees
- RLGT N/A
- CCCC N/A
- Industry
- RLGT Oil Refining/Marketing
- CCCC Biotechnology: Pharmaceutical Preparations
- Sector
- RLGT Consumer Discretionary
- CCCC Health Care
- Exchange
- RLGT Nasdaq
- CCCC Nasdaq
- Market Cap
- RLGT 295.7M
- CCCC 244.9M
- IPO Year
- RLGT N/A
- CCCC 2020
- Fundamental
- Price
- RLGT $6.29
- CCCC $1.52
- Analyst Decision
- RLGT
- CCCC Buy
- Analyst Count
- RLGT 0
- CCCC 4
- Target Price
- RLGT N/A
- CCCC $12.50
- AVG Volume (30 Days)
- RLGT 169.4K
- CCCC 777.7K
- Earning Date
- RLGT 05-08-2025
- CCCC 05-07-2025
- Dividend Yield
- RLGT N/A
- CCCC N/A
- EPS Growth
- RLGT 32.26
- CCCC N/A
- EPS
- RLGT 0.29
- CCCC N/A
- Revenue
- RLGT $858,699,000.00
- CCCC $35,584,000.00
- Revenue This Year
- RLGT $12.86
- CCCC N/A
- Revenue Next Year
- RLGT $5.75
- CCCC $36.32
- P/E Ratio
- RLGT $21.47
- CCCC N/A
- Revenue Growth
- RLGT N/A
- CCCC 71.44
- 52 Week Low
- RLGT $4.83
- CCCC $1.39
- 52 Week High
- RLGT $7.94
- CCCC $8.08
- Technical
- Relative Strength Index (RSI)
- RLGT 44.00
- CCCC 25.37
- Support Level
- RLGT $6.04
- CCCC $1.79
- Resistance Level
- RLGT $6.35
- CCCC $2.28
- Average True Range (ATR)
- RLGT 0.15
- CCCC 0.15
- MACD
- RLGT 0.02
- CCCC -0.02
- Stochastic Oscillator
- RLGT 59.76
- CCCC 14.61
About RLGT Radiant Logistics Inc.
Radiant Logistics Inc operates as a third-party logistics company, providing multi-modal transportation and logistics services to customers based in the United States and Canada. The company offers domestic and international air and ocean freight forwarding services and freight brokerage services including truckload services, less-than-truckload (LTL) services, and intermodal services. It has two geographic operating segments: the United States and Canada. Maximum revenue is generated in the United States.
About CCCC C4 Therapeutics Inc.
C4 Therapeutics Inc is a biopharmaceutical company advancing targeted protein degradation science to develop a new generation of small-molecular medicines to transform how the disease is treated. Its TORPEDO platform enables the discovery of a new class of targeted investigational small-molecule medicines called protein degraders.